D

Dr Soliman Abdel Kader Fakeeh Hospital Company SCJSC
SAU:4017

Watchlist Manager
Dr Soliman Abdel Kader Fakeeh Hospital Company SCJSC
SAU:4017
Watchlist
Price: 58.2 SAR 1.93% Market Closed
Market Cap: ﷼9B

EV/OCF

20.6
Current
5%
Cheaper
vs 3-y average of 21.7

Enterprise Value to Operating Cash Flow (EV/OCF) ratio compares a company`s total enterprise value to its operating cash flow. It shows how much investors are paying for each dollar of the company`s operating cash flow, including both equity and debt.

EV/OCF
20.6
=
Enterprise Value
﷼9.4B
/
Operating Cash Flow
﷼453.9m

Enterprise Value to Operating Cash Flow (EV/OCF) ratio compares a company`s total enterprise value to its operating cash flow. It shows how much investors are paying for each dollar of the company`s operating cash flow, including both equity and debt.

EV/OCF
20.6
=
Enterprise Value
﷼9.4B
/
Operating Cash Flow
﷼453.9m

Valuation Scenarios

Dr Soliman Abdel Kader Fakeeh Hospital Company SCJSC is trading below its 3-year average

If EV/OCF returns to its 3-Year Average (21.7), the stock would be worth ﷼61.27 (5% upside from current price).

Statistics
Positive Scenarios
3/4
Maximum Downside
-14%
Maximum Upside
+33%
Average Upside
7%
Scenario EV/OCF Value Implied Price Upside/Downside
Current Multiple 20.6 ﷼58.2
0%
3-Year Average 21.7 ﷼61.27
+5%
5-Year Average 21.7 ﷼61.27
+5%
Industry Average 27.5 ﷼77.59
+33%
Country Average 17.7 ﷼50.09
-14%

Forward EV/OCF
Today’s price vs future operating cash flow

Not enough data available to calculate forward EV/OCF

Peer Comparison

All Multiples
EV/OCF
P/E
All Countries
Close

Market Distribution

In line with most companies in Saudi Arabia
Percentile
58th
Based on 207 companies
58th percentile
20.6
Low
1.1 — 12.3
Typical Range
12.3 — 26.3
High
26.3 —
Distribution Statistics
Saudi Arabia
Min 1.1
30th Percentile 12.3
Median 17.7
70th Percentile 26.3
Max 1 696.8

Dr Soliman Abdel Kader Fakeeh Hospital Company SCJSC
Glance View

Market Cap
9B SAR
Industry
Health Care

In the bustling hub of healthcare innovation within the Kingdom of Saudi Arabia, Dr. Soliman Abdel Kader Fakeeh Hospital Company SCJSC stands out as a beacon of medical excellence and pioneering spirit. Founded to address the rising demand for quality healthcare services in the region, the company has grown from a single hospital into a comprehensive network of medical facilities. The core of its operations revolves around providing a full spectrum of healthcare services ranging from basic outpatient treatments to intricate surgical procedures and specialty care. The company integrates advanced medical technologies with a patient-focused care approach, ensuring that the population it serves receives both cutting-edge and compassionate treatment. Within its walls, dedicated teams of healthcare professionals work tirelessly to uphold a legacy of trust and expertise, attracting both local and international patients seeking superior medical attention. Financially, Dr. Soliman Abdel Kader Fakeeh Hospital Company operates through a multifaceted model that revolves around patient services, strategic partnerships, and insurance collaborations. By catering to a diverse array of medical needs, the company secures a steady revenue stream from its inpatient and outpatient services. Moreover, it has established alliances with various insurance companies, streamlining the payment processes for insured patients and enhancing financial access to healthcare services. Strategic expansions and the introduction of specialized units also contribute significantly to its revenue, allowing it to capture more market share and cater to niche medical needs. The organization's business acumen is evident in its ability to balance quality care with economic sustainability, ensuring its growth while maintaining high standards of healthcare delivery across the kingdom.

Intrinsic Value
43.15 SAR
Overvaluation 26%
Intrinsic Value
Price ﷼58.2
D
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett